Superseded public profile

In clinical trials↗Metabolic↗

Superseded · version 2: Cagrilintide↗

Related names recorded in this version: AM833↗

A long-acting amylin analogue under study. This profile cites a recruiting ClinicalTrials.gov record.↗

This is preserved historical wording.
It is no longer the current profile. Read the canonical profile and its correction notice.
Update · July 27, 2026

We rewrote the profile summary to describe the cited study record more directly. The cited source and status did not change. 1

What this version reported

ClinicalTrials.gov lists a Novo Nordisk pediatric study as recruiting, updated July 17, 2026.↗

Organizations named in cited records:
  • Novo Nordisk A/S↗

Trial records: NCT07253285

Sources for this version

  1. 1
    Cagrilintide and CagriSema in Children and Adolescents With Excess Body Weight · record history version 5 · last update posted 2026-07-17 ↗

    ClinicalTrials.gov · Official source · Source checked July 22, 2026